Fountain Life Co-founder and CEO Bill Kapp on why longevity’s next evolution will be adoption into mainstream healthcare.
The Founders Longevity Forum returns to London this June, drawing a curated group of entrepreneurs, investors and longevity leaders to discuss the evolving contours of the healthy human lifespan. Among the speakers is Dr William Kapp, co-founder and CEO of Fountain Life, a trailblazer in the design and deployment of data-driven longevity clinics. As the market matures, physical and digital clinical models are converging – offering individuals not only early disease detection but also personalized therapeutic pathways to slow or even reverse aging trajectories.
Fountain Life has positioned itself at the intersection of proactive healthcare and AI, with clinical sites already serving thousands of members and capturing one of the world’s largest datasets on asymptomatic individuals. Under Kapp’s leadership, the company has embraced an ecosystem model – layering genomics, imaging, metabolomics and AI analytics into a continual loop of feedback between patient and physician. The vision is to embed longevity into mainstream care pathways; first via precision clinics, then through digital tools capable of scaling best practices across health systems globally.
As part of the London Forum’s session on Longevity Clinics, Kapp will speak on building a digital and AI-enabled clinical network – one that empowers clinicians to synthesize torrents of biomarker data, and patients to engage meaningfully with their own healthspan trajectories. Plus, in conversation with Founders Health Co-founder and CEO Stephen Watson, Kapp will explore the opportunities around physical and digital clinics for the professional diagnosis of health and aging biomarkers and engage in an audience Q&A moderated by Joanna Bensz, Founder & CEO, Longevity Centre Europe.
Longevity.Technology We have long tracked the shift from reactive healthcare to a preventative, personalized and data-intensive future – Fountain Life exemplifies this transition. From AI co-pilots that translate clinical complexity into patient action, to advanced diagnostics that reveal hidden pathology long before symptoms arise, Bill Kapp and his team are charting new territory in functional medicine. Ahead of the Forum, we sat down with him to discuss capturing the train of thought between patient and doctor, why functional medicine defies a cookie-cutter approach, and cellular therapeutics that address immunosenescence.
Bill Kapp on…
A digital partner that remembers what you forget
One of the challenges of medicine is that it is a little bit art and, hopefully, a lot of science – but it’s still a little bit of art. And when we start talking about correcting disease… there are a lot of opinions out there. What we’re doing is we’re starting to capture the chain of thought between the patient and the doctor for the first time. Now in a matter of minutes, the AI can create those summaries for our team and then also start to work down the challenge of what are the recommendations. Our AI platform Zori is as bad as she’ll ever be today – she will only get better.
Personalizing protocols – why real functional medicine resists standardization
We have 15 functional medicine trained physicians who know kind of root cause analysis, but they all have a slightly different bent on how they want to treat the patient. It’s not cookie cutter. What is imperatively obvious is healthcare systems, when they are finally tasked with the full healthcare responsibility, are going to have to find a way to keep those patients healthier longer term. Regulatorily, it is a challenge – there is just so much regulatory oversight. But at the end of the day, we are not going to lower healthcare costs for anybody and improve outcomes until we start detecting problems early and fixing them early. You have to detect these problems, just like you would on an airliner. You want to make sure your pilot is at a full prevention check before he gets into the cockpit – you don’t want the problem at 40,000 feet.
The data doesn’t lie – even if you feel fine
We’re getting ready to publish our early cardiac data using the very first large biomarker series… it’s eye-opening data. It certainly calls into question some of the current pathways that we’re using to treat heart disease – nobody’s as healthy as they think they are, your body’s very good at masking disease.
We’ll show the data and demonstrate how Zori analyzes this data for our clinicians at the Forum, and at the same time how it works for our members as what we really want is parity of information flow between our members and the clinicians – once you pay for the data, it’s your data.
Cracking institutional inertia – why longevity needs a better interface
Like governments, healthcare systems move glacially. When the pain of staying the same exceeds the pain of change, that’s when they generally change. There’s really no ‘longevity program’ out there… what we’re interested in is how do we bring this application layer in and start to create longevity as an option for these systems that right now see those dollars going out of their system – and we’ve been approached by people from all over the world that want to put a Fountain Life in.
Banking today’s biology for tomorrow’s medicine
Your body’s inherently complicated… 40 trillion cells, billion chemical reactions per cell per second. It’s not going to be just one single small molecule that’s going to reverse your aging. We think there’s going to be a big role for adult stem cell banking, particularly starting to address the areas of immunosenescence. The latest thing we’re seeing is using exosomes and secretomes to retrain the immune system.
Rethinking “healthy” – what asymptomatic really means in a longevity clinic
What we’ve been doing over the last four-and-a-half years at Fountain is really collecting what we think is one of the largest data sets on asymptomatic individuals. By definition, if you’re asymptomatic, the current health system tells you you’re healthy. We know that’s not true. While I don’t believe that your doctor is going to be replaced by AI anytime soon, I do firmly believe that your physician not using AI will definitely be replaced because the data becomes too overwhelming for them to constantly keep up-to-date. This is where the best tool will really be able to affect that change.
